Low Dose Naltrexone (LDN)
The treatment you’ve never heard of… Why haven’t you heard about this amazing new breakthrough for conditions ranging from autoimmunity to cancer? Perhaps because as of yet no company has stepped forward with the billions of dollars needed to do a large-scale study on low-dose naltrexone (LDN). Unfortunately getting FDA-approval for use is not a straightforward process. With the patent expired, no drug company has been willing to pay such a large sum when they cannot sell the drug exclusively. However, if you check PubMed, there are currently over 90 studies published on the various uses of LDN, from pain relief, fibromyalgia, Crohn’s disease, multiple sclerosis, systemic sclerosis and even cancer. I have been using this drug in clinical practice with great results for the past several years and I want to tell you about it… So how does LDN work? Researchers at The Pennsylvania State University College of Medicine , Hershey, Pennsylvania have discovered the mechanism by which a low dose of the opioid antagonist naltrexone, an agent used clinically (off-label) to treat cancer and autoimmune diseases, exerts a profound inhibitory effect on cell proliferation. We believe that opioid receptor […]
LDN (low-dose naltrexone) with Drs Carnahan and Vasquez from ICHNFM.org on Vimeo.
Click here to view original web page at Low Dose Naltrexone: The New Treatment You’ve Never Heard Of…